The global nasal packing devices market is expected to reach a market valuation of US$ 189.4 million by 2023, accelerating with a moderate CAGR of 5.1% from 2023 to 2033. The nasal packing devices market size is anticipated to be valued at about US$ 311.9 million by 2033 end.
The demand for nasal packing devices is growing due in large part to the rising incidence of epistaxis. Epistaxis affected more than 12% of the world's population in 2021, with 75% of those affected needing medical intervention, according to the International Journal of Otolaryngology.
Hypertension is thought to be the key cause of epistaxis, a frequent clinical disease characterized by bleeding from the nostrils. The nasal packing devices market is benefiting from hypertension's rising prevalence. Pregnancy causes nosebleeds because the blood vessels expand, and more blood flows through them.
Consequently, the nasal packing devices industry is being driven by an increase in pregnant women with hypertension illnesses. The rising incidence of nasal malignancies is also driving the demand for nasal packing devices.
Despite this, the demand for nasal packing devices is hampered by consequences such as mucosal lacerations, which can increase bleeding, create infectious complications, and result in toxic shock syndrome (TSS). As a result, the nasal packing devices industry is expected to contract because of this factor.
However, the adoption of nasal packing devices is driven by an increase in products being introduced and a persistent emphasis on technological advancements.
| Attributes | Value |
|---|---|
| Nasal Packing Devices Market Size (2023) | US$ 189.4 million |
| Nasal Packing Devices Market Projected Size (2033) | US$ 311.9 million |
| Nasal Packing Devices Market Value CAGR (2022 to 2033) | 5.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The Rising Incidence of epistaxis is expected to fuel demand for Nasal Packing Devices.
According to a study published in the International Journal of Otolaryngology in 2015, epistaxis affects between 10 and 12 percent of the global population, with 80 percent of those affected requiring medical attention because the condition does not improve without treatment. The nasal packaging device market is projected to expand as a result of an increase in nosebleed cases.
The American Pregnancy Association states that a woman's circulatory system enlarges during pregnancy. Due to the increase in blood production and circulation, pregnant women may experience more frequent nosebleeds and other complications.
Growth of the global nasal packing devices industry is therefore anticipated to be driven by the rising prevalence of hypertension illnesses among pregnant women throughout the forecast period. The demand for nasal packing devices is additionally bolstered by the rising incidence of benign and malignant nasal tumors.
| Segment | Non-absorbable |
|---|---|
| Market Share % (2022) | 54.80% |
About 54.80% of the revenue in 2022 came from the non-absorbable nasal packing devices industry category. Non-absorbable nasal packing devices have been around longer, are doctors' first choice, and cost less than their bioresorbable counterparts.
Due to technical developments and the launch of novel brands, the bioresorbable category is expected to grow quickly over the forecast period. For patients, the reduced discomfort and additional benefits of bioresorbable nasal packing devices make them preferable.
| Segment | Spray |
|---|---|
| Market Share % (2022) | 31.20% |
In terms of nasal packing devices' revenue share in 2022, the spray segment was well ahead of the competition at 31.20%.
An emerging product, spray nasal packing, can be sprayed directly into the nose or onto cotton balls and inserted into the nose. A variety of nasal sprays, including saline and decongestant varieties, are in the nasal packing devices industry.
Over the projected time frame, the gel packaging nasal packing devices industry is expected to expand at a rate higher than any other.
Gel's excellent patient comfort and its hemostatic capabilities are projected to help the nasal packing devices segment's expansion, as are new advances and the efficacy of gel production.
Most people who suffer from nosebleeds turn to gel and bandages as their first line of defense. There is a wide selection of dressings from which to choose. MeroGel, made by Medtronic, is a well-liked nasal dressing. Postoperative nasal packing with injectable material is recommended to prevent central turbinate lateralization and nasal adhesions.
Principal Consultant
| North America Nasal Packing Devices Industry Share % (2022) | 37.5% |
|---|---|
| The United States Nasal Packing Devices Industry Share % (2022) | 31.2% |
With more and more people in the region suffering from epistaxis and more and more companies entering the market, nasal packing devices in North America were the most popular and generated significant revenue in 2022. The demand for nasal packing devices was already high before the rise in COVID-19 cases in the region.
| Country | Market Share % (2023 to 2033) |
|---|---|
| China | 6.2% |
| India | 5.1% |
From 2023 to 2033, the Asia Pacific region is expected to post the highest nasal packing devices industry growth rate worldwide. High unmet requirements, a thriving economy, and an overall improvement in healthcare facilities, particularly in developing countries like China and India, are mostly responsible for this expansion.
Additionally, the expansion of the nasal packing devices industry is due to the rising level of public understanding of nasal packing devices and the roles they play.
Nasal packing devices industry participants are continuously encouraged to invest and focus substantially on research and development operations to produce new and creative products in response to the rapidly growing technology and demand for nasal packing goods.
The nasal packing devices industry is expanding thanks, in part, to the proliferation of manufacturers providing products with cutting-edge capabilities. Nasal packing device manufacturers are expected to increase their market share through product launches, mergers, and acquisitions over the forecast period.
In November 2022, Aptar Pharma collaborated with TFF Pharmaceuticals. The former’s intranasal Unidose Powder Nasal Spray System was combined with the latter’s Thin Film Freezing technology platform to create and try out dry powder vaccine administration.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
New nasal packing devices industry participants are involved in research and development for technological advancements and nasal packaging device innovation. Smith & Nephew introduced a line of nasal packaging devices featuring RAPID RHINO technology, a carboxymethylcellulose (CMC) blend with self-lubricating properties that provide gentle and even compression to the nasal area and aid in the rapid re-conformation of the nasal anatomy. Similar technological advancements and strategic implementations by emerging and established market players are expected to drive the global nasal packaging device market forward.
Rise in the Adoption of Bioresorbable Nasal Packing
Nasal packing is used after sinus surgery to help stop bleeding and support the area's separated tissues and structures. The bioresorbable nasal packing aids in healing by reducing the risk of adhesion formation between the nasal mucosa and the underlying nasal bone.
And because it dissolves slowly and is cleared naturally, you won't have to go through the discomfort of removing your nasal packing.
For a stress-free recovery of patients, a variety of bioresorbable nasal packing products in a range of sizes, fragmentation times, compression strengths, and hemostatic properties are offered. Nasal packing devices come in a variety of compression strengths to ensure proper blood clotting, structural support, and adhesion avoidance.
Dissolvable nasal packing products allow for mucosal drainage. In addition, you can save time during surgery because no additional preparation, such as mixing, moistening, or using injection syringes, is required.
Medtronic’s Advent Into The Industry
After receiving FDA clearance in October, Medtronic ($MDT) introduced NovaShield Injectable Nasal Packing and Stent for functional endoscopic sinus surgery (FESS). After sinus or nasal surgery, a chitosan gel is inserted into the affected area.
Patient discomfort is reduced because the entire NovaShield does not need to be removed at once, as with traditional sponge or gauze packing.
Polymer chitosan is extracted from chitin, a component of the external shell of shellfish with properties that improve bleeding control. In patients taking antiplatelet or anticoagulant medications, which make hemostasis more difficult, the use of this first chitosan-based packing from Medtronic is associated with rapid hemostasis and fewer adhesions.
Absorbable Biomaterials: A New Way Forward
After endoscopic sinus surgery, absorbable biomaterials are frequently used for hemostasis and wound healing. Removable nasal packing is the standard treatment for stopping bleeding and regulating wound healing, but it causes patients discomfort and has its own risks.
In animal and human trials, absorbable agents currently on the market have been shown to provoke an inflammatory response, which slows the wound healing process. Modern agents' rapid clearance profiles and novel chemical composition provide significant benefits. Surgeon preference and case details should guide the choice of packing material for a given sinus procedure.
Summit Health and Olympus are the key manufacturers in the global market.
The market is forecast to register a CAGR of 5.1% through 2033.
From 2018 to 2022, the market registered a CAGR of 5.1%.
Development of cutting-edge equipment is driving the global market opportunities.
The global market size is to reach US$ 311.9 million by 2033.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Injectable 5.2. Gel 5.3. Spray 5.4. Dressings 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 6.1. Bio-resorbable 6.2. Non-absorbable 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Western Europe 7.4. Eastern Europe 7.5. South Asia and Pacific 7.6. East Asia 7.7. Middle East and Africa 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Summit Health 17.2. Smith & Nephew 17.3. Stryker Corporation 17.4. Medtronic plc. 17.5. Network Medical Products Ltd. 17.6. Olympus 17.7. Lohmann & Rauscher 17.8. Meril Life Sciences Pvt Ltd. 17.9. FABCO 17.10. Seraph Life Sciences Pvt Ltd. 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Nasal Packing Devices Market
